BTZ-043 Dose Evaluation in Combination and Selection

NCT05926466 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary
Other Specified Pulmonary Tuberculosis

Interventions

DRUG: BTZ-043
DRUG: Bedaquiline
DRUG: Delamanid
DRUG: Moxifloxacin

Sponsor

Michael Hoelscher

Collaborators

[object Object]
[object Object]
[object Object]